English
accueilESweb.jpg 
  

aeeh2010.jpg

04/03/10, Congress, Spain

Fibroscan®: a Constant Partner for Hepatologists at the AEEH Congress

Once again, Echosens Iberia is the indispensable actor at the yearly Spanish venue for Hepatologists: the XXXV Congress of the Spanish Association for Liver Diseases (AEEH) held in Madrid from February 17th to February 19th.


More about »

  

press.jpg

05/02/10, New release

FibroScan® expands its application to NASH / NAFLD patients

To meet the urgent need for non invasive alternative two teams of experts from France (head by Pr de Ledinghen) and Hong Kong (head by Pr Wong) demonstrate that the FibroScan® can be the revolutionary tool that the clinical practitioners dream of.


More about »

  

f_gasl_16.jpg

05/02/10, Congress, Germany

A highly representative FibroScan® presence at the GASL Congress

This growing numbers of posters and communications demonstrate the interest of the doctors for this tool.


More about »

  

evaluacionfibroscan_agenciaespaoladetecnologiasmedicas_ministeriocienciaeinnovacion_page_001.jpg

03/02/10,  Evaluation, Spain

Transient Elastography excels with Honours

Spanish Ministry of Science & Innovation confirms Transient Elastography’s vital role in diagnosis and follow up of chronic liver diseases.


More about »

  

hepatology512.gif

20/01/10, Publication, Hepatology 51(2): 454-462

New clinical data on NAFLD

FibroScan® performs significantly better than all studied blood markers on Non-Alcoholic Fatty Liver Disease.


More about »

  

fibroscan_2.jpg

14/01/10, Event, Spain

The Costa del Sol tests the Fibroscan®

“Convenient, Comfortable and Conclusive”, they unanimously conclude after one day of free Fibrocan® exams in Málaga.


More about »

  

fast50_laureat2009.jpg

19/11/09, New Award, Europe

ECHOSENS, Laureate 2009

Echosens is classified 23rd of the classification Deloitte Technology Fast 50 France on 2009 which rewards the technological firms of growth and 148th of the European Honours list Fast 500. Echosens knew a growth rate 1157% of the turnover over five financial years (2004-2008).


More about »

  

homologation_canada.jpg

03/08/09, Market, Canada

Market Clearance

The FibroScan® and its three dedicated probes (S, M & XL) have recently received clearance from Health Canada.

More about »

  
 
© Echosens 2008 | Contact | HEADQUARTERSEchosens SA
153, avenue d’Italie
75013 PARIS
FRANCE